Pharma Product Market Analyst Consultant (Contract)

Pantalent; United Kingdom; Remote; GBP 44,000 - 74,000; Part time

Job summary

A biotech startup is seeking an experienced Pharmaceutical Product/Market Analyst Consultant to provide critical guidance for Dendritic Cell therapies. The role involves market research, competitor analysis, and developing commercialization strategies. Ideal candidates will have at least 5 years of experience and a relevant degree. This position allows flexibility in remote or hybrid engagement.

Benefits

Flexible work hours

Remote work option

Engagement with pioneering biotech projects

Qualifications

• Minimum of 5 years of direct experience in pharmaceutical or biotech market analysis.
• Demonstrated experience with early-stage Biotech assets in a startup environment.
• Proven track record of delivering high-quality market insights.

Responsibilities

• Conduct comprehensive primary and secondary market research.
• Develop robust market size estimations and sales forecasts.
• Research pricing strategies, reimbursement models, and market access hurdles.

Skills

Market research expertise

Analytical acumen

Communication

Strategic thinking

Software proficiency

Education

Bachelor's degree in a scientific discipline or Business/Economics

Advanced degree (MBA, PhD, PharmD)

Tools

Microsoft Excel

Microsoft PowerPoint

Market intelligence databases (e.g., EvaluatePharma, DRG)

Job description

Location: Flexible/Remote

Company: Longevity Labs (part of Great Good Venture Studio)

Engagement Type: Contract / Freelance

About Great Good

Great Good is a pioneering venture studio at the intersection of biotech and AI. We launch transformative therapeutic projects by providing initial investment, world-class teams, and state-of-the-art infrastructure. Our model empowers visionary leaders to accelerate drug development and harness AI-driven innovation to address unmet medical needs. Benefits of Working with Great Good Venture Studio

• Accelerated Development:

  Our venture studio model streamlines the typically lengthy process of biotech innovation. With access to expert operational, legal, finance, and HR teams, you can bypass common startup hurdles and focus immediately on scientific advancement and strategic growth.

• Integrated Resource Access:

  You will have direct access to state-of-the-art labs, cutting-edge infrastructure, and specialized development and product teams tailored to your project’s unique needs—facilitating rapid iteration and optimized drug development pipelines.

• Collaborative Synergies:

  Joining our venture studio connects you with a vibrant ecosystem of experienced entrepreneurs, distinguished scientists, and industry leaders. This collaborative environment encourages cross-pollination of ideas, mentoring opportunities, and strategic partnerships, enhancing both innovation and your professional growth.

• Strategic Support and Investment:

  Beyond initial capital, Great Good provides ongoing strategic guidance and operational support. Our comprehensive back-office resources help manage day-to-day complexities while our investment in your venture ensures you have the means to scale quickly and capture market opportunities.

• Enhanced Commercial Potential:

  By working under the venture studio umbrella, you not only drive scientific breakthroughs but also elevate the commercial viability of your project. Our model is designed to maximize innovation in drug therapeutics and generate significant market value, positioning your venture for long-term success and impactful industry leadership.

About Longevity Labs

Longevity Labs is a diversified life science company with a strong interest in gene therapy, oncology, and longevity spaces. One project under consideration is an autologous Dendritic Cell (DC), therapy for solid tumors. Cell therapies have been growing at 18.9% CAGR fueled mainly by the CAR-T sector, but CAR-T has been mostly unsuccessful in solid tumors which make up 90% of the market. While DC therapies are regarded as very safe, they have not achieved a high level of clinical benefit in patients. Low cell dose numbers and activation states, poor routes of administration, and limited antigen range are all obstacles that our DC technology has demonstrated its ability to overcome in preclinical testing. The core technology has FDA approval for Phase I trials, but needs optimization on the I.P., scale manufacture and antigen production areas. Our plan is to leverage emerging technologies in gene sequencing and CAR-T manufacture to present a compelling narrative to Series A investors and potential Pharma partners.

The Opportunity

We are seeking an experienced Pharmaceutical Product/Market Analyst Consultant to provide critical strategic guidance as we advance our lead asset to human trials. As a rapidly growing biotech startup, we require deep market intelligence to inform our development strategy, commercialization planning, and investor communications. This role will be crucial in shaping our understanding of the market landscape and optimizing our path to impact.

Key Responsibilities

• Market Landscape Analysis: Conduct comprehensive primary and secondary market research to understand the current and future market dynamics for Dendritic Cell therapies for cancer. This includes:
• • Disease incidence, prevalence, and patient populations.
  • Current standard of care, treatment pathways, and unmet medical needs.
  • Key opinion leader (KOL) insights and physician perspectives.
  • Competitor analysis, including pipeline assessments, clinical trial data, and commercial strategies of existing and emerging players.

• Market sizing & forecasting: develop robust market size estimations and realistic sales forecasts for our DC therapy across relevant geographic regions, considering various scenarios and assumptions.

• Pricing & reimbursement strategy: research and analyze potential pricing strategies, reimbursement models, and market access hurdles in key markets, providing recommendations aligned with our product's value proposition.

• Value proposition development: work collaboratively with our scientific and leadership teams to refine and articulate the unique value proposition of our therapeutic candidates to various stakeholders: patients, physicians, payers, investors.

• Go-to-market strategy input: provide strategic input into potential commercialization pathways, including target patient segments, potential partnership models, and early commercialization considerations.

• Competitive intelligence: continuously monitor the competitive landscape, identifying emerging threats and opportunities, and assessing their potential impact on our strategy.

• Data synthesis & reporting: synthesize complex market data into clear, concise, and actionable insights. Prepare comprehensive reports, presentations, and dashboards for leadership, the Board of Directors, and potential investors.

• Ad-hoc analysis: provide timely market analysis and insights to support strategic decision-making on an as-needed basis.

Qualifications:

• Education: Bachelor's degree in a scientific discipline (e.g., Biology, Biochemistry, Pharmacology) or Business/Economics. An advanced degree (MBA, PhD, PharmD) is highly preferred.Experience:
  • Minimum of 5 years of direct experience in pharmaceutical or biotech market analysis, competitive intelligence, market access consulting, or a related role within a consulting firm, market research agency, or pharmaceutical/biotech company.

  • Demonstrated experience working with early-stage Biotech assets in a startup or fast-paced environment is highly desirable.

  • Proven track record of delivering high-quality, actionable market insights and strategic recommendations.

  • Specific experience in oncology, cell, and gene therapies is a significant advantage.

  Skills:
  • Market research expertise: proficient in both primary and secondary market research methodologies.

  • Analytical acumen: exceptional analytical and quantitative skills, with the ability to interpret complex data, identify trends, and build robust financial models.

  • Communication: excellent written and verbal communication skills, with the ability to present complex information clearly and persuasively to diverse audiences (scientists, business leaders, investors).

  • Strategic thinking: strong ability to connect market insights to strategic business implications and translate data into actionable recommendations.

  • Industry knowledge: deep understanding of the drug development lifecycle, regulatory pathways, pharmaceutical commercialization, and healthcare payer systems.

  • Software proficiency: advanced proficiency in Microsoft Excel and PowerPoint. Experience with market intelligence databases (e.g., EvaluatePharma, DRG, Cortellis, AdisInsight) is highly desirable.

  • Independence & proactivity: ability to work independently, manage multiple projects, and deliver high-quality results within agreed-upon timelines, often with limited direct supervision.

  • Collaboration: while independent, ability to collaborate effectively with internal scientific and business teams.

To Apply:

Interested candidates should submit a detailed resume/CV and a cover letter outlining their relevant expertise, experience in market analysis for early-stage biotech assets, and your proposed hourly or project-based consulting rate via the application form. Please also indicate your availability and preferred engagement model.